TY  - JOUR
PY  - 2009//
TI  - Lantus overdose: case presentation and management options
JO  - Journal of emergency medicine
A1  - Fuller, Everett T.
A1  - Miller, Michael A.
A1  - Kaylor, David W.
A1  - Janke, Cliff
SP  - 26
EP  - 29
VL  - 36
IS  - 1
N2  - Insulin glargine (Lantus, Aventis Pharmaceuticals, Bridgewater, NJ) is a long-acting once-daily dosed form of insulin intended to maintain a constant baseline insulin level. As a relatively new medication, there is limited experience in overdoses of Lantus. We present a case of a 37-year-old male insulin-dependent diabetic presenting with refractory hypoglycemia secondary to an intentional overdose of Lantus insulin to illustrate the varied management concerns in overdoses of long-acting insulins. The patient was managed with oral intake, intravenous dextrose bolus, peripheral 10% dextrose solution, 25% dextrose sliding scale via central line, and psychiatry evaluation for suicide attempt. Other potential treatments discussed for possible use with long-acting insulin overdoses include incision and drainage of the injection site, glucagon, and octreotide.<p /> <p>Language: en</p>
LA  - en
SN  - 0736-4679
UR  - http://dx.doi.org/10.1016/j.jemermed.2007.02.038
ID  - ref1
ER  -